Aiming to capitalize on the opportunities in the inoperable
liver cancer market,
) unveiled Emprint Ablation System with Thermosphere Technology -
an advanced ablation system designed to precisely heat and destroy
diseased soft tissue in the liver, lungs and kidney.
The Emprint Ablation System enables physicians to deliver precise
ablation directly to soft tissue, including liver tumors. This
innovative technology ensures more certainty regardless of the
target location or tissue type, thus making liver tumor ablation
Covidien's Ablation System provides clinicians with three kinds of
spatial energy control - thermal, field and wavelength. This helps
them to create predictable and spherical ablation zones regardless
of target location, tissue type or changes in tissue properties
during a procedure.
By providing predictable spherical ablation zones, this technology
offers physicians more choices in terms of approach, further
simplifying needle placement and saving planning and procedure
A liver tumor ablation procedure destroys the tumor without
removing it, thus providing an alternative to open surgery
resection or other treatments. This method is ideal for patients
for whom surgical removal of tumors is not an optimal solution.
With Covidien's Ablation System, physicians can treat liver tumor
by non-surgical procedures. They utilize ultrasound or CT scanning
to guide the system's antenna and insert it directly into the tumor
through the skin. Apart from non-surgical procedures, Covidien's
advanced ablation system can also be used for minimally invasive
surgery and open surgery.
In Apr 2014, Covidien received the U.S. Food and Drug
Administration 510(k) clearance for its Emprint Ablation System. In
addition, the company completed all European requirements for
attaining the CE Mark for the product. Covidien expects to fully
launch the Emprint Ablation System in the U.S. and the European
Union in the present quarter.
Currently, Covidien carries a Zacks Rank #4 (Sell). Better-ranked
stocks in the medical products industry include
Wright Medical Group Inc.
). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
COVIDIEN PLC (COV): Free Stock Analysis Report
WRIGHT MEDICAL (WMGI): Free Stock Analysis
CAREFUSION CORP (CFN): Free Stock Analysis
ALERE INC (ALR): Free Stock Analysis Report
To read this article on Zacks.com click here.